Synergizing Patent and Regulatory Strategies

On May 30, Yeon Jae Ko will be speaking at ACI's Annual Life Sciences Patents conference in New York on the panel "Synergizing Patent and Regulatory Strategies: Enhancing Profitability and Compliance in the Life Sciences." This session will detail the strategic integration of patent prosecution and regulatory compliance, highlighting the benefits of collaboration between USPTO and FDA. This synergy, driven by USPTO's duty to disclose, ensures compliance while enhancing profitability via smarter patent drafting.

Topics of discussion will include:

• Appreciating the evolution of USPTO-FDA collaboration
  
  • Taking stock of the evolving partnership and understanding the impact on patent prosecution and regulatory approvals
• Exploring the considerations and best strategies for aligning prosecution and regulatory strategy at specific phases:
  
  • Early stage
  • Clinical
  • Approval and commercial launch
  • Pre-ANDA investigation and early litigation
  • Expiration of regulatory exclusivity
  • Litigation, IPR, and PGRs
• Considering the synergy of prosecution and regulatory from the due diligence perspective

To register click here.